Survey regarding pregnant women receiving novel antipsychotic agents
10.11256/jjdi.11.35
- VernacularTitle:非定型抗精神病薬服薬妊婦に関する症例集積調査
- Author:
RITSUKO YAMANE
;
MASAHIRO HAYASHI
;
MASA TANAKA
;
KAYOKO HISHINUMA
;
KAYOKO OGAWA
;
IKUKO YOKOO
;
HIROAKI KITAGAWA
- Publication Type:Journal Article
- Keywords:
pregnancy;
olanzapine;
risperidone;
quetiapine fumarate;
perospirone hydrochloride hydrate
- From:Japanese Journal of Drug Informatics
2009;11(1):35-38
- CountryJapan
- Language:Japanese
-
Abstract:
Objective: Novel antipsychotic agents less frequently cause extrapyramidal side effects compared to conventional antipsychotic agents, contributing to improvement in the QOL. Recently, these agents have also been increasingly prescribed to females who may become pregnant. In Japan, no epidemiological survey regarding the application of novel antipsychotic agents in pregnant women has been published. In this study, we investigated the influence on fetuses in pregnant women receiving novel antipsychotic agents.
Methods: In pregnant women on novel antipsychotic agents who consulted the Pregnancy and Drug Consultation Outpatient Clinic of Toranomon Hospital, the outcome of pregnancy was confirmed.
Results: Twenty-nine pregnant women took novel antipsychotic agents in the organogenesis phase, in which the risk of teratogenicity is the highest. The agents consisted of olanzapine in 8 patients, risperidone in 11, quetiapine fumarate in 7, and perospirone hydrochloride hydrate in 4. The outcomes of pregnancy were full-term delivery in 24 patients, premature delivery in 1, spontaneous abortion in 2, and artificial abortion in 2. Of the 29 patients, 15 (60%) had continuously taken these agents until delivery. All 25 neonates were healthy without malformation.
Conclusion: This report describes the first prospective survey in Japan regarding infants delivered by pregnant women receiving novel antipsychotic agents. All patients delivered healthy neonates; the incidence of congenital anomalies did not exceed that in the general population. This survey included a small number of patients; cohort studies should be conducted to evaluate the safety in fetuses.
